Navigation Links
Beware Fake Ebola Treatments on the Internet, FDA Says
Date:8/15/2014

FRIDAY, Aug. 15, 2014 (HealthDay News) -- As the death toll in the West Africa Ebola outbreak passes 1,000, the U.S. Food and Drug Administration is warning against products sold online that claim to treat the deadly disease or prevent infection.

Since the start of the Ebola outbreak in West Africa, the FDA has received a number of consumer complaints about bogus products, the agency said in a statement released Thursday.

However, "there are no approved vaccines, drugs, or investigational products specifically for Ebola available for purchase on the Internet," the FDA said.

"Individuals promoting these unapproved and fraudulent products must take immediate action to correct or remove these claims or face potential FDA action," the agency added.

It is also against the law for makers of dietary supplements to claim that their products prevent or cure disease, the FDA said.

Some experimental Ebola vaccines and treatments are being developed, but they are still in the early stages and have not undergone thorough testing for safety and effectiveness.

Most are also in extremely limited supply, the FDA said. Two U.S. Ebola patients, Dr. Kent Brantly and Nancy Writebol, are slowly recovering after receiving doses of one experimental medicine called Zmapp. Only a handful of doses of the drug have been manufactured so far, and prior to the patients receiving it Zmapp had only been tested in animals.

The FDA also stressed that, according to data from the U.S. Centers for Disease Control and Prevention, Ebola does not pose a significant threat to the U.S. public.

The virus is not a water-borne or food-borne illness and is not transmitted through the air, the FDA said. Ebola is only spread through direct contact with the body fluids of an infected person, or through needles and other items that have been contaminated with the virus.

According to the World Health Organization, the current outbreak of Ebola has killed 1,066 people in Guinea, Liberia, Nigeria and Sierra Leona, and sickened 2,000 more.

More information

Find out more on Ebola at the U.S. Centers for Disease Control and Prevention.

SOURCE: U.S. Food and Drug Administration, news release, Aug. 14, 2014

--


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Beware of claims about cosmetic stem cells procedures, says review in Plastic and Reconstructive Surgery
2. Its Buyer Beware for Decorative Contact Lenses, FDA Says
3. Buyer Beware: Organic Soils Not Always So “Organic”
4. Beware of OTC Head Lice Products, says Lice Busters, America's #1 All Natural Lice Treatment Brand
5. Beware: Newly recognized heart cardiomyopathy is not always benign
6. Beware Fake Flu Treatments, FDA Warns
7. Parents and readers beware of stereotypes in young adult literature
8. Carnivores: Beware of ticks
9. Beware of the Potato Salad: Preventing Foodborne Illness in Summer
10. Home Elder Care: Buyer, Beware
11. San Francisco Bath Salt Company Clears Air About Bath Salt Confusion – Zombies Beware!
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Beware Fake Ebola Treatments on the Internet, FDA Says
(Date:4/24/2017)... ... 2017 , ... Donna Parker, L. Ac. reads all sorts of books on ... to be very practical. She wanted to write a guide/workbook that would give readers ... It prompted her in writing “ A Clear Path to a Vibrant Life : ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue ... Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau Hotel ...
(Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is ... the process rendered in my Art and Music. These are created as Metaphysical Transformations ... the boundary of mystery culminate to the ultimate singularity.", -- Karen Salicath Jamali , ...
(Date:4/22/2017)... (PRWEB) , ... April 22, 2017 , ... ... to his role as Vice President of Sales and Business Development at OAKWORKS, ... GPO/IDN business partner engagements, business development, and strategic planning for the company. ...
(Date:4/21/2017)... ... April 21, 2017 , ... Contrary ... that youth violence is declining—and at noteworthy rates. Between 2002 and 2014, Salas-Wright ... people involved in violence in the United States. The study, Trends in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
Breaking Medicine Technology: